New US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he intends to save $1.8 billion per year, ...

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

Eli Lilly's direct-to-consumer platform LillyDirect has been expanded to include in-person and telehealth services for people ...

At JP Morgan 2025, pharmaphorum editor-in-chief Jonah Comstock sat down with Dr Michael Bauer, CEO of Quantro Therapeutics, about his company’s novel approach to gene transcription factor control.

While AZ is eyeing overseas expansion with its new investment, J&J has embarked on a reshoring drive with a pledge to invest ...

Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader-Willi syndrome (PWS), a rare genetic ...

“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...